This page lists the points that most often need care in a news story about CJD and other prion diseases. The site does not run a press office and does not supply quotes. Where a story needs an expert, use the named professional bodies and surveillance centres in the sources, and check figures against the latest release from the relevant national centre.
What are the basic facts?
Creutzfeldt-Jakob disease (CJD) is a rare, fatal brain condition caused by prions, abnormal infectious proteins. Worldwide it causes about 1 to 2 deaths per million people each year, and the CDC reports about 500 to 600 cases a year in the United States. Most people are in their late 60s at onset. The NHS gives a similar rate for the UK, about 1 or 2 per million for the sporadic form. There is no cure, and care focuses on comfort and symptom relief.
Which type of CJD is the story about?
Type decides almost every other fact, so name it.
- Sporadic CJD, about 85 percent of cases. The cause is not fully understood.
- Genetic (familial) CJD, about 5 to 15 percent, linked to an inherited change in the prion protein gene.
- Acquired CJD, which is rare. It includes cases after contaminated surgical equipment (the CDC lists six known cases, none reported since 1976), human growth hormone made before 1978, and dura mater or corneal transplants from donors with undetected CJD.
- Variant CJD, linked to eating meat from cattle with BSE. The CDC states that CJD and variant CJD are different diseases. The NHS adds that variant CJD has rarely spread through blood transfusion, and that variant and iatrogenic cases are now very uncommon.
BSE (“mad cow disease”) is a prion disease of cattle. Chronic wasting disease affects deer and elk. These are animal diseases and should not be used as a synonym for CJD.
What do public sources not tell you?
- Official counts depend on surveillance. A rate quoted for one country may not apply to another with different testing and reporting.
- Duration varies. The CDC page gives both about a year and, in a sidebar, 4 to 5 months for usual survival from symptom onset. Quote the source and its wording rather than a single figure.
- A news report of one case does not show a rise in cases. Compare it with the usual annual numbers.
How should families and patients be handled?
Do not identify a patient or relative without clear consent from them or their family. Avoid describing symptoms of named people. Do not offer readers advice on testing, genetics or treatment. Direct them to a clinician, a genetic counsellor or the national surveillance centre.
Where can I check further?
- How common is CJD and myths and facts for plain language explanations.
- Editorial policy for how this site handles evidence and review.
- Insurers and pharma for industry briefs, and the partners hub for the rest.